NASDAQ:AMBI AMBI (AMBI) Stock Price, News & Analysis → Urgent: Protect Your Investments from a Chinese Invasion (From Behind the Markets) (Ad) Free AMBI Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$5.51▼$5.6050-Day Range N/A52-Week Range N/AVolume3,813 shsAverage Volume7,915 shsMarket Capitalization$305.31 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisCompetitorsHeadlinesSocial MediaStock AnalysisCompetitorsHeadlinesSocial Media Get AMBI alerts: Email Address Ad Behind the MarketsUrgent: Protect Your Investments from a Chinese InvasionAn alarming new reality is unfolding across America. The United States is bracing for the unthinkable - a potential Chinese invasion.Click here to get my exclusive report NOW >>> About AMBI Stock (NASDAQ:AMBI)Ambit Biosciences Corporation is a biopharmaceutical company. The Company focused on the discovery, development and commercialization of drugs to treat unmet medical needs in oncology, autoimmune and inflammatory diseases by inhibiting kinases that are important drivers for those diseases. The Company’s lead drug candidate, quizartinib, is in Phase IIb clinical development in patients with relapsed/refractory acute myeloid leukemia (AML). The Company’s second drug candidate in clinical development, AC410, is a potent, selective, orally-administered, small molecule inhibitor of Janus kinase 2 (JAK2) that has potential utility for the treatment of autoimmune and inflammatory diseases. The Company’s third program consists of two selective small molecule compounds, AC708 and AC855, which inhibit the colony-stimulating factor-1 receptor (CSF1R), a receptor tyrosine kinase.Read More Ad Behind the MarketsUrgent: Protect Your Investments from a Chinese InvasionAn alarming new reality is unfolding across America. The United States is bracing for the unthinkable - a potential Chinese invasion.Click here to get my exclusive report NOW >>> AMBI Stock News HeadlinesMarch 25, 2024 | msn.comHollywood And Fans Are Already Buzzing Over Christopher Nolan's Next FilmMarch 22, 2024 | msn.comHow Hallmark Favorite Tyler Hynes Is Celebrating Women — and His Mom! — with New Movie “Shifting Gears” (Exclusive)March 28, 2024 | Porter & Company (Ad)AI to Meet the Same Fate as EVs? When these tech bubbles burst, they invariably leave investors disillusioned by their losses. Now, many worry a similar fate is awaiting AI. And one man, legendary financial analyst Porter Stansberry, who called Nvidia at $11… March 21, 2024 | cbsnews.comBusinesswomen connect and share secrets to success in HarlemMarch 21, 2024 | msn.comFeel Like You Can Be Both Poly *and* Monogamous? You Might Be AmbiamorousMarch 20, 2024 | msn.comQuantum Tornado Unveils Insights into Black Hole MysteriesMarch 18, 2024 | msn.com14 Best Drugstore Vitamin C Serums for Bright Skin, According to ExpertsMarch 15, 2024 | msn.comNavigating the CosmosMarch 28, 2024 | Porter & Company (Ad)AI to Meet the Same Fate as EVs? When these tech bubbles burst, they invariably leave investors disillusioned by their losses. Now, many worry a similar fate is awaiting AI. And one man, legendary financial analyst Porter Stansberry, who called Nvidia at $11… March 15, 2024 | msn.comCBD Punjab leads charge as Maryam Nawaz green lights Nawaz Sharif IT CityMarch 8, 2024 | stockhouse.comA Leap Forward in Laundry: Tide launches a revolutionary new tile form to transform laundry dayMarch 8, 2024 | msn.comThe booming business of tiny: Ambi Parameswaran, on how small packs got everywhereMarch 6, 2024 | msn.comEmpowering Women Drivers in PakistanMarch 6, 2024 | msn.comPCB chief advocates merit and unity for Pakistan cricket's ascendancyMarch 5, 2024 | msn.comRani: The Real Story On OTT: All You Need To Know About Release Date, Platform & CastFebruary 26, 2024 | msn.comTaita Taveta Deputy Speaker released on Sh1 million bondFebruary 22, 2024 | finance.yahoo.comBugs Be Gone! Zevo Gives You the Power of Two Traps in One With the New Zevo Max Flying Insect TrapFebruary 18, 2024 | msn.comMumbai: BMC Explores Ferry Ride Between Worli & Mahim To Boost TourismFebruary 18, 2024 | msn.comMumbai: Seafood plaza success leads to boat ride from Mahim to WorliFebruary 18, 2024 | msn.com10 classic American companies that aren't actually AmericanFebruary 16, 2024 | msn.comA TV star who became the voice of consumersFebruary 16, 2024 | msn.comThese Brightening Serums Deliver Radiant Skin That Glows 24/7February 14, 2024 | msn.comFallon Sgt. Kennedy L. Sanders remains return to her hometownFebruary 14, 2024 | msn.comSgt. Kennedy Sanders returns to her hometown of WaycrossFebruary 14, 2024 | news.yahoo.comSingularities are a pain in the neck for robot arms -- Jacobi Robotics is trying to solve themFebruary 12, 2024 | msn.comCrossing the RubiconFebruary 8, 2024 | msn.comAll 16 Premier League winning captains ranked on pure footballing abilitySee More Headlines Receive AMBI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for AMBI and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/06/2014Today3/28/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorIndustrial Products Industry Sanitary services Sub-IndustryN/A Current SymbolNASDAQ:AMBI CUSIPN/A CIK1131543 Webwww.hpxcorp.com Phone+1-858-3342100FaxN/AEmployees5,041Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio1.33 Current Ratio2.29 Quick Ratio2.23 Sales & Book Value Annual Sales$326.33 million Price / Sales0.94 Cash Flow$6.33 per share Price / Cash Flow0.87 Book Value$10.21 per share Price / Book0.54Miscellaneous Outstanding Shares55,410,000Free Float26,597,000Market Cap$305.31 million OptionableNot Optionable Beta0.64 The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key CompetitorsPerma-Fix Environmental ServicesNASDAQ:PESIGrahamNYSE:GHMQuad/GraphicsNYSE:QUADLuxferNYSE:LXFRDesktop MetalNYSE:DMView All Competitors AMBI Stock Analysis - Frequently Asked Questions How were AMBI's earnings last quarter? AMBI (NASDAQ:AMBI) announced its earnings results on Tuesday, May, 6th. The biopharmaceutical company reported ($0.50) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.47) by $0.03. The biopharmaceutical company earned $0.03 million during the quarter, compared to analyst estimates of $3.50 million. What ETF holds AMBI's stock? VanEck Environmental Services ETF holds 190,775 shares of AMBI stock, representing 2.15% of its portfolio. What other stocks do shareholders of AMBI own? Based on aggregate information from My MarketBeat watchlists, some companies that other AMBI investors own include Alexion Pharmaceuticals (ALXN), Amarin (AMRN), Broadcom (BRCM), Cytokinetics (CYTK), Delta Air Lines (DAL), Fortress Biotech (FBIO), FireEye (FEYE), Five Prime Therapeutics (FPRX), Glu Mobile (GLUU) and Halozyme Therapeutics (HALO). This page (NASDAQ:AMBI) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingFed launches fourth dollar overhaulStansberry ResearchForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AMBI Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.